Drug Shortage Report for CIPRO ORAL SUSPENSION

Last updated on 2024-07-16 History
Report ID 229988
Drug Identification Number 02237514
Brand name CIPRO ORAL SUSPENSION
Common or Proper name CIPROFLOXACIN SUSPENSION
Company Name BAYER INC
Market Status MARKETED
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 500MG
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10g/100mL
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-07-01
Actual start date 2024-07-03
Estimated end date 2024-07-16
Actual end date 2024-07-15
Shortage status Resolved
Updated date 2024-07-16
Company comments Supply delay
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2024-07-16 English Compare
v16 2024-07-15 French Compare
v15 2024-07-15 English Compare
v14 2024-07-12 French Compare
v13 2024-07-12 English Compare
v12 2024-07-04 English Compare
v11 2024-07-03 French Compare
v10 2024-07-03 English Compare
v9 2024-07-03 French Compare
v8 2024-07-03 English Compare
v7 2024-07-02 English Compare
v6 2024-06-19 French Compare
v5 2024-06-19 English Compare
v4 2024-06-07 French Compare
v3 2024-06-07 French Compare
v2 2024-06-07 English Compare
v1 2024-06-07 English Compare

Showing 1 to 17 of 17